医学
叙述性评论
重症监护医学
病危
红细胞输注
麻醉学
红细胞
评论文章
输血
复苏
危重病
过程(计算)
梅德林
止痛药
重症监护
作者
Romain Tymen,Elaine Cavalcante dos Santos,Fabio Silvio Taccone,Cécile Aubron
标识
DOI:10.1007/s00134-026-08304-w
摘要
There is a need for additional determinants in the RBC transfusion decision process to offset the limitations of RBC transfusion based only on Hb level in non-bleeding critically ill patients. A multimodal strategy, including comorbidities, underlying diseases, clinical signs, ECG changes, biochemical markers, and microcirculatory assessment, may optimise transfusion timing and avoid unnecessary red blood cell administration. However, further research is warranted to determine the potential benefit of integrating tissue oxygenation and microcirculatory parameters in the transfusion decision-making process.
科研通智能强力驱动
Strongly Powered by AbleSci AI